Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result? :[PAUTHORS], Journal of Medical Physics

ORIGINAL ARTICLE
Year : 2022 | Volume : 47 | Issue : 2 | Page : 189--193

Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?

Mohamad Aminudin Bin Said¹, Hairil Rashmizal Abdul Razak², Marianie Bnti Musarudin³,
¹ Department of Nuclear Medicine, Institut Kanser Negara, Putrajaya, Malaysia
² Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
³ School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kelantan, Malaysia

Correspondence Address:
Mr. Mohamad Aminudin Bin Said
Department of Nuclear Medicine, Institut Kanser Negara, Putrajaya
Malaysia

Abstract

Peptide Receptor Radionuclide Therapy (PRRT) is the administration of a radionuclide, such as the Lu-177 label, along with a pharmaceutical agent to destroy the lesion cell. The first cycle of Lu-177 DOTA-TATE is an excellent way to estimate radionuclide uptake for organs at risk. To estimate the absorbed dose for a kidney, serial SPECT-CT imaging with up to five sets is required. In general, serial CT on patients would result in additional external exposure and extra time consuming, especially for low dose CT such as cone beam CT technology. However, by introducing a new method, such as optimized single CT (24 h) to perform with serial SPECT attenuation correction, additional external exposure from serial CT exposure could be reduced. Aims: The purpose of this study is to assess the agreement between single CT scanning as CT attenuation Correction with serial CT scanning for serial SPECT imaging as well as estimated absorbed dose to the organ at risk. Settings and Design: During the first cycle of Lu177-DOTA-TATE, all patients should undergo internal dosimetry technique using SPECT-CT imaging with a PHILIP Brightview XCT gamma camera. The quantifications of SPECT images are being used to measure the uptake activity to the organ. In this investigation, Partik's categorical grading criteria are being used to convert the numeric value of Lin's concordance coefficient into an ordinal scale. Method: Total of 9 patients at our institution was administered with Lu177-DOTA-TATE enroll in this study. SPECT-CT data were acquired using automatic body contouring with a total of 48 angular views at steps of 6° (15 s/projections). The pixel size is 4.66 x 4.66 x 4.66 mm, the images size set to one, and SPECT data has been acquired for three-bed positions extending from the abdomen to the thorax region. Low-dose CT imaging performed at an X-ray tube voltage of 120 kVp. Results: Our current result demonstrated by single CT scanning for SPECT attenuation shown the excellent agreement with standard serial CT imaging for organs at risk such as kidney 0.999, spleen 0.9951, liver 0.9951 and bladder 0.9972. Conclusions: When compared to the previous method, patients benefit significantly more from this study, such as lower CT exposure.

How to cite this article:
Said MA, Razak HR, Musarudin MB. Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?.J Med Phys 2022;47:189-193

How to cite this URL:
Said MA, Razak HR, Musarudin MB. Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?. J Med Phys [serial online] 2022 [cited 2023 Mar 31 ];47:189-193
Available from: https://www.jmp.org.in/text.asp?2022/47/2/189/353332

Full Text

Introduction

Single-photon emission computed therapy with computed tomography (SPECT-CT) is an imaging technique that can observe the distribution of SPECT radiopharmaceuticals within the target organ. SPECT-CT is the ideal nuclear medicine imaging system in peptide receptor radionuclide therapy (PRRT) to investigate abnormal organ uptake in patients.[1],[2] For PRRT procedure, internal dosimetry technique is useful to estimate the absorbed dose (AD) to the organ at risk. The kidneys are the most important organ for this therapy, and the total AD should be less than 23 Gy and as high as 40 Gy for the biologically effective dose (BED) to be approached.[3],[4],[5],[6] The unique property of Lu-177, which emits low-gamma energy and generates medium beta particles, makes it the ideal choice for nuclear medicine theranostic imaging.[7] The 7.4 GBq of Lu-177-DOTA-TATE is administrated to the patients each therapy cycle as standard practice.[4],[5] Radionuclide dosimetry technique for Lu-177-DOTA-TATE therapy suitable to be carried out at the first cycle. To estimate the AD for a kidney, five sets of serial SPECT-CT imaging are necessary.[8] Serial CT to the patients would, in general, expose the patients to more radiation and take longer, even with low-dose CT such as cone-beam CT technology. However, offering a novel approach, such as an optimized single CT (24 h) to be used in conjunction with serial SPECT attenuation correction, could help to reduce additional external exposure from serial CT exposure. The time it takes to acquire a CT scan would also be greatly decreased. The goal of this study is to assess the AD agreement for organs at risk between a single attenuation CT with serial CT as a reference (gold standard).

Methods

A total of nine patients at our institution was administered with Lu-177-DOTA-TATE enrolled in this study. During the first cycle of Lu-177-DOTA-TATE, all patients must undergo internal dosimetry procedure with SPECT-CT imaging using a Philips BrightView XCT gamma camera. SPECT-CT data were acquired using automatic body contouring with a total of 48 angular views at steps of 6° (15 s/projections). The pixel size is 4.66 mm × 4.66 mm × 4.66 mm, the size of the image is set to one, and SPECT data has been acquired for three-bed positions extending from the abdomen to the thorax region. The SPECT image quantifications are used to measure the organ's uptake activity. The SPECT activity calibration procedure had explained in previous publications.[9],[10] CT images reconstructed with Iterative Iteration algorithm 8 Iteration with 16 Subset with scatter correction as recommended by the manufacturer.

Applied used for attenuation correction. Low-dose CT imaging was performed at an X-ray tube voltage of 120 kVp. The X-ray tube current is set to 20 mA for all imaging time points. The same CT image was also used for the SPECT attenuation correction and as well for image registration of different time points. CT data reconstructed with iterative method algorithm with pixel size 2.00 mm × 2.00 mm and a slice thickness of 2.75 mm. Data from nine procedures with complete sets of uptake measurements 2, 4, 24, 48, and 72 h after intravenous administration of 7.4 GBq was used to estimate AD for kidneys, spleen, liver, and bladder. To determine the agreement between two sets, the reconstruction of SPECT images was classified into two groups.

SET A belongs to the serial CT used for serial SPECT attenuation correction and SET B refers to the single CT (24 h) used for serial SPECT attenuation correction, as shown in [Figure 1]. All the registrations between the CT and the subsequent SPECTs were done semiautomatically in Philips Extended BrightView Workstations. Image analysis for time disintegration was performed using the MIM software version. 9.4.6 Encore Module. Internal dosimetry software was used to estimate the AD to the targeted organ for both sets. The flowchart in [Figure 2] summarizes the steps to reach an agreement between SET A and B.{Figure 1}{Figure 2}

Statistical methods

Lin's concordance was used to analyze the AD agreement between two groups to the kidneys, liver, spleen, and bladder. Lin's concordance correlation coefficient is a measure of how well a set of bivariate data (Y) compares to a “gold standard” measurement or test (X) as referring to [Figure 1] and [Figure 2],[11] for example,[12] suggests the following guidelines for interpreting Lin's concordance correlation coefficient <0.90: poor, 0.90–0.95: moderate, 0.95–0.99: substantial, and >0.99: almost perfect.

Results

The administered activity of Lu177-DOTA-TATE was 7.489 ± 0.259 GBq. The absorbed dose to the organ address in Gy/GBq, the study based on the number of disintegrations occurring in a source organ such as kidney, liver, spleen and bladder. [Figure 3] illustrates an excellent agreement between Set A and B, especially kidney 0.999, spleen 0.9951, liver 0.9951, and bladder 0.9972.{Figure 3}

Discussion

The CT component attached with the gamma camera is very critical to perform attenuation correction for SPECT images. CT imaging also leads to highly accurate anatomic localization of SPECT imaging. This hybrid modality performed within the same couch with imaging artifacts induced by patient movements easily reduced by using MIM Encore software. The current results show AD for the critical organ done by single CT attenuation and serial CT attenuation shown a good agreement. It should be noted that previous studies have indicated that kidney AD is between 5.30% ± 6.20%, respectively.[9] They use the semiautomated SPECT-based segmentation method to get a good agreement result. According to [Figure 3], the almost perfect agreement between both sets leads to the new ideas that benefit the single CT imaging in serial SPECT imaging. Our institutional clinical protocol required 24 h SPECT-CT acquisition to verify the radionuclide uptake to the organ. In line with our institutional clinical protocol, the optimization of 24-h CT attenuation correction is beneficial to optimize the single CT imaging to determine AD. Based on our initial null hypothesis, there was no difference in the method of CT attenuation technique of the patients between the two sets of protocols. The agreement between the two data set is nearly perfect, particularly for kidney 0.999, spleen 0.9951, liver 0.9951, and bladder 0.9972. The accuracy of this result is dependent on several factors such as the type of software used to analyze the images, camera calibration efficiency, CT attenuation capability, and accurate dosimetry software package.[10],[12],[13],[14]

Although Philips BrightView gamma camera used low-dose CT, the SPECT images corrected with the iterative reconstructed technique give a consistent result. Astonish reconstruction systems software had introduced by Philips is an image restoration process to enhance the image resolution for SPECT images as shown in [Figure 4]. This technique by using the blind deconvolution technique is currently the most widely used iterative reconstruction technique and provides better image quality and consistent value. The organ volume segmentation from CT images will be transferred and fused with serial SPECT images.[15],[16] The SPECT imaging protocol was similar to another center in which no scatters correction was applied but produced acceptable results.{Figure 4}

The accuracy of the result from the number of disintegrations occurring in a source organ is very crucial to estimate the accurate result, as shown in Equation 1. The SPECT segmentation method is less accurate than with positron emission tomography radiopharmaceutical due to its physical properties.[17],[18],[19] The AD to whole organs, tissue subregions, voxelated tissue structures, and individual cellular compartments from internally deposited radionuclides define below.

[INLINE:1]

Where DD̄ referred to AD at the target organ, rt and rs refer to target and source organ, A ̃rs refer to cumulated activity at target organ and S[Gy] (rt → rs) is the mean AD per cumulated activity form rs to rt. A ̃rs is very critical to estimate the dose to the critical organ. In this study, the cumulated activity A ̃rs derived directly by the area under the time-activity curve that plots the effective disappearance of activity in an organ, or the integral may be approximate by standard methods such as the trapezoidal rule.

Our current result [Figure 3] showed that SET A (Reference) had an excellent agreement with SET B. The low CT imaging was very challenging to delineate organ volume segmentation, especially at the spleen organ due to the density of the spleen density. The CT forms high dose will help to delineate the accurate segmentation easily but give a higher dose to the organ as pointed out before.[20],[21] Different patient positioning (e.g., SPECT imaged with arms stretched upward, and whole-body imaged with arms next to the body) may have led to an internal shift of organs and lesions as reported before.[21] That issue can be reduced by using a patient vacuum bag during SPECT acquisitions. The vacuum bag to use immobilization of patients during serial SPECT acquisition to avoid mispositioning organs and lesions. The CT-based segmentation resulted in an almost perfect agreement of the organ definitions with a similar renal dose by using MIM box-based assisted alignment features. As we understand, the protocol of Lu-177-DOTA-TATE dosimetry takes about 3 to 4 days to complete, this option is useful when the CT system had a failure during the procedure. From the standpoint of CT radiation exposure, this option allows for a reduction of up to 80% in nontherapeutic patient exposure, and radiation workers would be able to conduct more patients. Consistent with other findings, single CT exposure radiation would be lower when compared to the serial set of CT imaging used in PRRT dosimetry for CT over the abdomen.[22]

Conclusions

Single CT imaging for SPECT attenuation is the best alternative option to estimate AD to the organ at risk for dosimetry technique. This option also will ensure the patient is more comfortable by an optimized single CT imaging procedure. Hybrid imaging approaches combining SPECT-CT provide a compromise between accuracy and user-friendliness. Further, prospective studies are warranted to assess the benefits of Lu-177-DOTA-TATE postdosimetry for the individual patient and the patient outcome.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1	Kupitz D, Wetz C, Wissel H, Wedel F, Apostolova I, Wallbaum T, et al. Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios. PLoS One 2017;12:e0187570.
2	Sundlöv A, Gustafsson J, Brolin G, Mortensen N, Hermann R, Bernhardt P, et al. Feasibility of simplifying renal dosimetry in ¹⁷⁷Lu peptide receptor radionuclide therapy. EJNMMI Phys 2018;5:12.
3	Delker A, Fendler WP, Kratochwil C, Brunegraf A, Gosewisch A, Gildehaus FJ, et al. Dosimetry for (177)Lu-DKFZ-PSMA-617: A new radiopharmaceutical for the treatment of metastatic prostate cancer. Eur J Nucl Med Mol Imaging 2016;43:42-51.
4	Garske-Román U, Sandström M, Fröss Baron K, Lundin L, Hellman P, Welin S, et al. Prospective observational study of177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): Feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity. Eur J Nucl Med Mol Imaging 2018;45:970-88.
5	Sandström M, Garske-Román U, Granberg D, Johansson S, Widström C, Eriksson B, et al. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment. J Nucl Med 2013;54:33-41.
6	Sundlöv A, Sjögreen-Gleisner K, Svensson J, Ljungberg M, Olsson T, Bernhardt P, et al. Individualised ¹⁷⁷Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry. Eur J Nucl Med Mol Imaging 2017;44:1480-9.
7	El-Nesr MS, Bashandy E. The decay of Lu177 to Hf177. Nucl Phys 1962;31:128-38.
8	Sandstrom M, Garske-Roman U, Granberg D, Johansson S, Widstrom C, Eriksson B, et al. Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment, J Nuclear Med 2013. doi: 10.2967/jnumed.112.107524.
9	Chicheportiche A, Artoul F, Schwartz A, Grozinsky-Glasberg S, Meirovitz A, Gross DJ, et al. Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT). EJNMMI Phys 2018;5:10.
10	Sanders JC, Kuwert T, Hornegger J, Ritt P. Quantitative SPECT/CT imaging of (177) Lu with in vivo validation in patients undergoing peptide receptor radionuclide therapy. Mol Imaging Biol 2015;17:585-93.
11	Lin LI, McBride G, Bland JM, Altman DG. A Proposal for Strength-of-Agreement Criteria for Lin's CONCORDANCE Correlation Coefficient. NIWA Client Report; 2005.
12	Bailey DL, Willowson KP. An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med 2013;54:83-9.
13	Zhao W, Esquinas PL, Hou X, Uribe CF, Gonzalez M, Beauregard JM, et al. Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes. EJNMMI Phys 2018;5:8.
14	Halty A, Badel JN, Kochebina O, Sarrut D. Image-based SPECT calibration based on the evaluation of the fraction of activity in the field of view. EJNMMI Phys 2018;5:11.
15	Deak PD, Smal Y, Kalender WA. Multisection CT protocols: Sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology 2010;257:158-66.
16	Gear JI, Charles-Edwards E, Partridge M, Flux GD. A quality-control method for SPECT-based dosimetry in targeted radionuclide therapy. Cancer Biother Radiopharm 2007;22:166-74.
17	Hartmann H, Freudenberg R, Oehme L, Zöphel K, Schottelius M, Wester HJ, et al. Dosimetric measurements of 68Ga-High Affinity DOTATATE. Nuklearmedizin 2014;53:211-6.
18	Weber DA. The MIRD method of estimating absorbed dose. J Nucl Med 1990;(16).
19	Frey EC, Humm JL, Ljungberg M, Morgan RH. Accuracy and precision of radioactivity quantification in nuclear medicine images reliability of quantitative images NIH public access. Semin Nucl Med 2012;42:208-18.
20	Christner JA, Kofler JM, McCollough CH. Estimating effective dose for CT using dose-length product compared with using organ doses: Consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning. AJR Am J Roentgenol 2010;194:881-9.
21	Valentin J; International Commission on Radiation Protection. Managing patient dose in multi-detector computed tomography (MDCT). ICRP Publication 102. Ann ICRP 2007;37:1-79, iii.
22	Kalra MK, Maher MM, Toth TL, Hamberg LM, Blake MA, Shepard JA, et al. Strategies for CT radiation dose optimization. Radiology 2004;230:619–28.